We are live on ! Find out more
HIM

HGC Investment Management Portfolio holdings

AUM $451M
1-Year Est. Return 8.78%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+8.78%
3 Year Est. Return
+34.39%
5 Year Est. Return
+41.74%
10 Year Est. Return
–
AUM
$472M
AUM Growth
+$61.2M
Cap. Flow
+$59.5M
Cap. Flow %
12.61%
Top 10 Hldgs %
26.73%
Holding
185
New
61
Increased
4
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
DMII
Drugs Made In America Acquisition II Corp
DMII
+$12.2M
2
SBXE.U
SilverBox Corp V Units
SBXE.U
+$9.07M
3
PAII
Pyrophyte Acquisition Corp II
PAII
+$8.55M
4
ITHAU
ITHAX Acquisition Corp III Units
ITHAU
+$7.97M
5
LPCVU
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
+$7.49M

Top Sells

Rank Stock Value
1
DMIIU
Drugs Made In America Acquisition II Corp Unit
DMIIU
+$11.9M
2
PAII.U
Pyrophyte Acquisition Corp II Units
PAII.U
+$8.61M
3
CGCTU
Cartesian Growth Corp III Unit
CGCTU
+$8.14M
4
VRNA
Verona Pharma
VRNA
+$7.88M
5
AEXA
American Exceptionalism Acquisition Corp
AEXA
+$7.75M

Sector Composition

Rank Sector Weight
1 Financials 37.95%
2 Technology 2.96%
3 Healthcare 1.72%
4 Communication Services 1.64%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AACB
1
Artius II Acquisition Inc
AACB
$292M
$15.4M 3.28%
1,500,000
– –
ALF
2
Centurion Acquisition Corp
ALF
$388M
$15.4M 3.27%
1,450,000
– –
JACS
3
Jackson Acquisition Co II
JACS
$317M
$15.4M 3.26%
1,475,200
-100,000
-6% -$1.04M
GPAT
4
GP-Act III Acquisition Corp
GPAT
$401M
$14.7M 3.12%
1,375,000
– –
SDHI
5
Siddhi Acquisition Corp
SDHI
$365M
$12.8M 2.72%
1,250,000
– –
DMII
6
Drugs Made In America Acquisition II Corp
DMII
$644M
$12.2M 2.58%
+1,230,980
New +$12.2M
FERAU
7
Fifth Era Acquisition Corp I Units
FERAU
$220M
$12M 2.55%
1,150,760
– –
OBAWU
8
Oxley Bridge Acquisition Ltd Unit
OBAWU
$230M
$9.7M 2.06%
950,000
– –
SOUL
9
Soulpower Acquisition Corp
SOUL
$353M
$9.67M 2.05%
953,146
-350,015
-27% -$3.55M
CYBR
10
DELISTED
CyberArk
CYBR
$8.7M 1.84%
19,507
+7,870
+68% +$3.79M
PAII
11
Pyrophyte Acquisition Corp II
PAII
$279M
$8.55M 1.81%
+850,000
New +$8.55M
EXAS
12
DELISTED
Exact Sciences
EXAS
$8.12M 1.72%
+80,000
New +$6.42M
ITHAU
13
ITHAX Acquisition Corp III Units
ITHAU
$201M
$7.98M 1.69%
+800,000
New +$7.97M
KFIIU
14
K&F Growth Acquisition Corp II Unit
KFIIU
$276M
$7.84M 1.66%
750,000
– –
EA icon
15
Electronic Arts
EA
$52.9B
$7.73M 1.64%
37,816
+10,316
+38% +$2.08M
PACHU
16
Pioneer Acquisition I Corp Units
PACHU
$229M
$7.59M 1.61%
743,077
– –
LPCVU
17
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
$201M
$7.49M 1.59%
+750,000
New +$7.49M
ADACU
18
American Drive Acquisition Co Units
ADACU
$205M
$7.48M 1.59%
+750,000
New +$7.48M
JENA
19
Jena Acquisition Corp II
JENA
$301M
$7.12M 1.51%
+700,000
New +$7.14M
EVAC.U
20
EQV Ventures Acquisition Corp II Units
EVAC.U
$7.06M 1.5%
697,174
– –
CEPF
21
Cantor Equity Partners IV
CEPF
$593M
$6.68M 1.42%
650,000
-600,000
-48% -$6.24M
SZZL
22
Sizzle Acquisition Corp II
SZZL
$325M
$6.61M 1.4%
650,539
– –
VHCPU
23
Vine Hill Capital Investment Corp II Units
VHCPU
$180M
$6.51M 1.38%
+650,000
New +$6.52M
AAM
24
DELISTED
AA Mission Acquisition Corp
AAM
$6.46M 1.37%
605,000
-600,000
-50% -$6.36M
MBVIU
25
M3-Brigade Acquisition VI Corp Units
MBVIU
$308M
$6.33M 1.34%
625,000
-225,000
-26% -$2.31M
1
2 3 4 5

Similar funds

CU
CDAM (UK) London, United Kingdom $451M AUM 6.84% 1-Year Est. Return
LVIA
Lind Value II ApS Aarhus C, Denmark $451M AUM 17.35% 1-Year Est. Return
SIM
SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return
AA
Addison Advisors Middlebury, Vermont $452M AUM 14.62% 1-Year Est. Return
MC
Magnitude Capital New York $450M AUM 43.9% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $453M AUM 12.19% 1-Year Est. Return
SMI
Shelter Mutual Insurance Columbia, Missouri $450M AUM 13.75% 1-Year Est. Return
ATI
Act Two Investors Santa Cruz, California $453M AUM 10.9% 1-Year Est. Return

HGC Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, HGC Investment Management held 185 positions worth $472M, up 15% from $411M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

HGC Investment Management deployed $59.5M of net new capital in Q4 2025, opening 61 new positions and adding to 4 existing holdings. Its largest new stake was Drugs Made In America Acquisition II Corp: 1,230,980 shares worth $12.2M.

By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 43% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was American Exceptionalism Acquisition Corp, an estimated $7.75M trimmed.

  • HGC Investment Management's largest Q4 2025 buy was Drugs Made In America Acquisition II Corp: 1,230,980 shares worth $12.2M.
  • HGC Investment Management added most to CyberArk in Q4 2025, an estimated $3.79M increase.
  • HGC Investment Management's biggest Q4 2025 reduction was American Exceptionalism Acquisition Corp, cutting an estimated $7.75M.
  • HGC Investment Management fully exited Drugs Made In America Acquisition II Corp Unit in Q4 2025, selling an estimated $11.9M.
  • HGC Investment Management's ten largest holdings make up 27% of its $472M portfolio in Q4 2025.
  • HGC Investment Management opened 61 new positions and closed 23 in Q4 2025.
  • HGC Investment Management's portfolio value rose 15% quarter-over-quarter to $472M.

Based on HGC Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.